Carl Byrnes

Stock Analyst at Northland Capital Markets

(0.50)
# 3,147
Out of 4,502 analysts
14
Total ratings
44.44%
Success rate
-11.33%
Average return

9 Stocks

Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $2.19
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $2$1.25
Current: $0.78
Upside: +59.36%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $8
Current: $0.48
Upside: +1,555.63%
BrainsWay
Nov 17, 2022
Maintains: Outperform
Price Target: $15$5
Current: $7.28
Upside: -31.32%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60$80
Current: $23.70
Upside: +237.55%
MiMedx Group
Jul 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.38
Upside: -
Esperion Therapeutics
May 5, 2021
Maintains: Market Perform
Price Target: n/a
Current: $2.34
Upside: -
Aytu BioPharma
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.75
Upside: -
Heron Therapeutics
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $3.15
Upside: -